Page 64 - TD-3-1

Tumor Discovery Mechanism of Buddleja officinalis against ESCC

doi: 10.1111/j.1349-7006.2012.02288.x cancer therapy: Current clinical outcomes. Acta Pharmacol
Sin. 2012;33(12):1441-1458.
30. Song Q, Liu Y, Jiang D, et al. High amplification of FGFR1
gene is a delayed poor prognostic factor in early stage ESCC doi: 10.1038/aps.2012.72
patients. Oncotarget. 2017;8(43):74539-74553.
39. Song M, Liu X, Liu K, et al. Targeting AKT with oridonin
doi: 10.18632/oncotarget.20215 inhibits growth of esophageal squamous cell carcinoma in
vitro and patient-derived xenografts in vivo. Mol Cancer
31. Takase N, Koma Y, Urakawa N, et al. NCAM-and FGF-2-
mediated FGFR1 signaling in the tumor microenvironment Ther. 2018;17(7):1540-1553.
of esophageal cancer regulates the survival and migration doi: 10.1158/1535-7163.MCT-17-0823
of tumor-associated macrophages and cancer cells. Cancer 40. Li B, Xu WW, Lam AK, et al. Significance of PI3K/AKT
Lett. 2016;380(1):47-58.
signaling pathway in metastasis of esophageal squamous cell
doi: 10.1016/j.canlet.2016.06.009 carcinoma and its potential as a target for anti-metastasis
therapy. Oncotarget. 2017;8(24):38755-38766.
32. Frater J, Lie D, Bartlett P, McGrath JJ. Insulin-like growth
factor 1 (IGF-1) as a marker of cognitive decline in normal doi: 10.18632/oncotarget.16333
ageing: A review. Ageing Res Rev. 2018;42:14-27.
41. Li J, Li Z, Xu Y, Huang C, Shan B. METTL3 facilitates
doi: 10.1016/j.arr.2017.12.002 tumor progression by COL12A1/MAPK signaling
pathway in esophageal squamous cell carcinoma. J Cancer.
33. Zhou Y, Li S, Li J, Wang D, Li Q. Effect of microRNA-135a 2022;13(6):1972-1984.
on cell proliferation, migration, invasion, apoptosis and
tumor angiogenesis through the IGF-1/PI3K/Akt signaling doi: 10.7150/jca.66830
pathway in non-small cell lung cancer. Cell Physiol Biochem. 42. Chen S, Yang W, Zhang X, et al. Melamine induces
2017;42(4):1431-1446. reproductive dysfunction via down-regulated the
doi: 10.1159/000479207 phosphorylation of p38 and downstream transcription
factors Max and Sap1a in mice testes. Sci Total Environ.
34. Choucair A, Pham TH, Omarjee S, et al. The arginine 2021;770:144727.
methyltransferase PRMT1 regulates IGF-1 signaling in
breast cancer. Oncogene. 2019;38(21):4015-4027. doi: 10.1016/j.scitotenv.2020.144727
doi: 10.1038/s41388-019-0694-9 43. Shi DM, Li LX, Bian XY, et al. miR-296-5p suppresses EMT
of hepatocellular carcinoma via attenuating NRG1/ERBB2/
35. Chu PC, Lin PC, Wu HY, et al. Mutant KRAS promotes ERBB3 signaling. J Exp Clin Cancer Res. 2018;37(1):294.
liver metastasis of colorectal cancer, in part, by upregulating
the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling doi: 10.1186/s13046-018-0957-2
pathway. Oncogene. 2018;37(25):3440-3455. 44. Lee YJ, Kim JS, Kang DG, Lee HS. Buddleja officinalis
doi: 10.1038/s41388-018-0222-3 suppresses high glucose-induced vascular smooth muscle
cell proliferation: Role of mitogen-activated protein kinases,
36. Wang G, Lu M, Yao Y, Wang J, Li J. Esculetin exerts antitumor nuclear factor-kappaB and matrix metalloproteinases. Exp
effect on human gastric cancer cells through IGF-1/PI3K/ Biol Med (Maywood). 2010;235(2):247-255.
Akt signaling pathway. Eur J Pharmacol. 2017;814:207-215.
doi: 10.1258/ebm.2009.009222
doi: 10.1016/j.ejphar.2017.08.025
45. Oh WJ, Jung U, Eom HS, et al. Inhibition of
37. Fresno Vara JA, Casado E, De Castro J, Cejas P, lipopolysaccharide-induced proinflammatory responses
Belda-Iniesta C, Gonzalez-Baron M. PI3K/Akt signalling by Buddleja officinalis extract in BV-2 microglial cells
pathway and cancer. Cancer Treat Rev. 2004;30(2):193-204.
via negative regulation of NF-kB and ERK1/2 signaling.
doi: 10.1016/j.ctrv.2003.07.007 Molecules. 2013;18(8):9195-9206.
38. Pal I, Mandal M. PI3K and Akt as molecular targets for doi: 10.3390/molecules18089195

Volume 3 Issue 1 (2024) 13 https://doi.org/10.36922/td.2312